Toll-like Receptors in Inflammation

Toll-like receptors (TLRs) are critical mediators of the innate immune response in mammals. This family of receptors recognizes a variety of microbial products or motifs and initiates the host response to infection. Examples include TLR4 which recognizes lipopolysaccharide (LPS) from Gram-negative b...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Coauteur: SpringerLink (Online service)
Andere auteurs: O'Neill, Luke A.J. (Redacteur, http://id.loc.gov/vocabulary/relators/edt), Brint, Elizabeth. (Redacteur, http://id.loc.gov/vocabulary/relators/edt)
Formaat: Elektronisch E-boek
Taal:English
Gepubliceerd in: Basel : Birkhäuser Basel : Imprint: Birkhäuser, 2005.
Editie:1st ed. 2005.
Reeks:Progress in Inflammation Research,
Onderwerpen:
Online toegang:https://doi.org/10.1007/3-7643-7441-1
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
LEADER 04530nam a22005655i 4500
001 978-3-7643-7441-9
003 DE-He213
005 20200704102514.0
007 cr nn 008mamaa
008 100301s2005 sz | s |||| 0|eng d
020 |a 9783764374419  |9 978-3-7643-7441-9 
024 7 |a 10.1007/3-7643-7441-1  |2 doi 
050 4 |a QR180-189.5 
072 7 |a MJCM  |2 bicssc 
072 7 |a MED044000  |2 bisacsh 
072 7 |a MJCM  |2 thema 
082 0 4 |a 616.079  |2 23 
245 1 0 |a Toll-like Receptors in Inflammation  |h [electronic resource] /  |c edited by Luke A.J. O'Neill, Elizabeth Brint. 
250 |a 1st ed. 2005. 
264 1 |a Basel :  |b Birkhäuser Basel :  |b Imprint: Birkhäuser,  |c 2005. 
300 |a XII, 246 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Progress in Inflammation Research,  |x 0379-0363 
505 0 |a TLRs as bacterial sensors -- Toll-like receptors and rheumatoid arthritis: is there a connection? -- Toll-like receptor 9 and systemic autoimmune diseases -- Toll-like receptors and airway disease -- Toll-like receptors and vascular disease -- Toll-like receptors and inflammatory bowel disease -- Toll-like receptor signaling in the liver -- Toll-like receptors as key sensors of viral infection -- IRAK-4: A key kinase involved in toll-like receptor signaling and resistance to bacterial infection -- Endogenous regulation of toll-like receptor signalling -- Tuning of inflammatory cytokines and toll-like receptors by TIR8/SIGIRR, a member of the IL-1 receptor family with unique structure and regulation -- Toll-like receptors as pharmacological targets. 
520 |a Toll-like receptors (TLRs) are critical mediators of the innate immune response in mammals. This family of receptors recognizes a variety of microbial products or motifs and initiates the host response to infection. Examples include TLR4 which recognizes lipopolysaccharide (LPS) from Gram-negative bacteria, TLR3 which recognizes viral double-stranded RNA, and TLR9 which recognizes CpG DNA motifs, found in both viruses and bacteria. All TLRs possess an intracellular region termed the Toll-IL-1 receptor-Resistance (TIR) domain which is essential for signaling from these receptors. The specificity of signaling from individual TLRs arises from differential utilization of adapter proteins. This specificity results in a tailoring of the host defense response depending on the microbe being sensed. TLRs are increasingly being implicated in both infectious and inflammatory diseases, notable examples being sepsis, inflammatory bowel disease, atherosclerosis, and asthma. There is, therefore, great interest in targeting TLRs therapeutically since a disruption of TLR function will result in a decrease in the production of inflammatory mediators. This volume covers our current understanding of TLRs and their role in inflammation. Given the importance of TLRs in the inflammatory process and their emerging role in inflammatory diseases the book is of great interest to researchers working in inflammation and immunology. 
650 0 |a Immunology. 
650 0 |a Infectious diseases. 
650 0 |a Medical microbiology. 
650 0 |a Cell biology. 
650 0 |a Pharmacology. 
650 1 4 |a Immunology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B14000 
650 2 4 |a Infectious Diseases.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33096 
650 2 4 |a Medical Microbiology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B16003 
650 2 4 |a Cell Biology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/L16008 
650 2 4 |a Pharmacology/Toxicology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B21007 
700 1 |a O'Neill, Luke A.J.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Brint, Elizabeth.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783764390785 
776 0 8 |i Printed edition:  |z 9783764372859 
830 0 |a Progress in Inflammation Research,  |x 0379-0363 
856 4 0 |u https://doi.org/10.1007/3-7643-7441-1 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)